Black Rock Inc. Stoke Therapeutics, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 5,409,169 shares of STOK stock, worth $61.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,409,169
Previous 3,858,463
40.19%
Holding current value
$61.2 Million
Previous $52.1 Million
40.29%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding STOK
# of Institutions
123Shares Held
57.6MCall Options Held
9.3KPut Options Held
35.2K-
Skorpios Trust8.91MShares$101 Million99.85% of portfolio
-
Lynx1 Capital Management LP San Juan, PR5.19MShares$58.7 Million22.82% of portfolio
-
Redmile Group, LLC San Francisco, CA4.71MShares$53.3 Million3.79% of portfolio
-
Rtw Investments, LP New York, NY4.65MShares$52.6 Million0.91% of portfolio
-
Baker Bros. Advisors LP New York, NY4.37MShares$49.4 Million0.57% of portfolio
About Stoke Therapeutics, Inc.
- Ticker STOK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,419,300
- Market Cap $446M
- Description
- Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...